Association between non-Hodgkin lymphoma and renal cell carcinoma

Chen Lossos, Annapoorna Ferrell, Robert Duncan, Izidore Lossos

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The incidence of patients with multiple primary tumors has been increasing in recent years. The association between non-Hodgkin lymphomas (NHL) and renal cell carcinoma (RCC) is unclear. The presentation of 10 patients with co-existent NHL and RCC at our institution in the past 3 years led us to explore whether this was a chance association or a statistically significant phenomenon. We used the US Surveillance, Epidemiology and End Results (SEER) program (www.seer.cancer.gov) from 1973 to 2006 to identify a total of 892 445 537 subjects aged 1884, with known values for race and gender at risk for NHL and RCC. Among these, 181 009 were diagnosed with NHL, 118 122 were diagnosed with RCC and 1039 had both NHL and RCC. This was significantly higher than the expected number of 24 with co-existent NHL and RCC (p < 0.0001). The observed number (O) of RCC after NHL was significantly higher than the expected number (E) (O/E: 1.51; 95% confidence interval [CI] 1.361.66), with the O/E ratio remaining elevated across the various follow-up time intervals. The observed number of NHL after RCC was not significantly different from the expected number (O/E: 1.09; 95% CI 0.981.22). In univariate analyses, race and gender were significantly associated with an increased cumulative incidence of RCC after NHL. Multivariate analysis with age, race and gender revealed that white males had a higher cumulative incidence of RCC after NHL. These findings suggest that patients with NHL are at increased risk for RCC.

Original languageEnglish
Pages (from-to)2254-2261
Number of pages8
JournalLeukemia and Lymphoma
Volume52
Issue number12
DOIs
StatePublished - Dec 1 2011

Fingerprint

Renal Cell Carcinoma
Non-Hodgkin's Lymphoma
Incidence
SEER Program
Confidence Intervals
Multivariate Analysis

Keywords

  • Non-Hodgkin lymphoma
  • Renal cell carcinoma
  • SEER

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Association between non-Hodgkin lymphoma and renal cell carcinoma. / Lossos, Chen; Ferrell, Annapoorna; Duncan, Robert; Lossos, Izidore.

In: Leukemia and Lymphoma, Vol. 52, No. 12, 01.12.2011, p. 2254-2261.

Research output: Contribution to journalArticle

Lossos, Chen ; Ferrell, Annapoorna ; Duncan, Robert ; Lossos, Izidore. / Association between non-Hodgkin lymphoma and renal cell carcinoma. In: Leukemia and Lymphoma. 2011 ; Vol. 52, No. 12. pp. 2254-2261.
@article{e57041faa78a40a9b8ddd73afd2ab782,
title = "Association between non-Hodgkin lymphoma and renal cell carcinoma",
abstract = "The incidence of patients with multiple primary tumors has been increasing in recent years. The association between non-Hodgkin lymphomas (NHL) and renal cell carcinoma (RCC) is unclear. The presentation of 10 patients with co-existent NHL and RCC at our institution in the past 3 years led us to explore whether this was a chance association or a statistically significant phenomenon. We used the US Surveillance, Epidemiology and End Results (SEER) program (www.seer.cancer.gov) from 1973 to 2006 to identify a total of 892 445 537 subjects aged 1884, with known values for race and gender at risk for NHL and RCC. Among these, 181 009 were diagnosed with NHL, 118 122 were diagnosed with RCC and 1039 had both NHL and RCC. This was significantly higher than the expected number of 24 with co-existent NHL and RCC (p < 0.0001). The observed number (O) of RCC after NHL was significantly higher than the expected number (E) (O/E: 1.51; 95{\%} confidence interval [CI] 1.361.66), with the O/E ratio remaining elevated across the various follow-up time intervals. The observed number of NHL after RCC was not significantly different from the expected number (O/E: 1.09; 95{\%} CI 0.981.22). In univariate analyses, race and gender were significantly associated with an increased cumulative incidence of RCC after NHL. Multivariate analysis with age, race and gender revealed that white males had a higher cumulative incidence of RCC after NHL. These findings suggest that patients with NHL are at increased risk for RCC.",
keywords = "Non-Hodgkin lymphoma, Renal cell carcinoma, SEER",
author = "Chen Lossos and Annapoorna Ferrell and Robert Duncan and Izidore Lossos",
year = "2011",
month = "12",
day = "1",
doi = "10.3109/10428194.2011.603443",
language = "English",
volume = "52",
pages = "2254--2261",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Association between non-Hodgkin lymphoma and renal cell carcinoma

AU - Lossos, Chen

AU - Ferrell, Annapoorna

AU - Duncan, Robert

AU - Lossos, Izidore

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The incidence of patients with multiple primary tumors has been increasing in recent years. The association between non-Hodgkin lymphomas (NHL) and renal cell carcinoma (RCC) is unclear. The presentation of 10 patients with co-existent NHL and RCC at our institution in the past 3 years led us to explore whether this was a chance association or a statistically significant phenomenon. We used the US Surveillance, Epidemiology and End Results (SEER) program (www.seer.cancer.gov) from 1973 to 2006 to identify a total of 892 445 537 subjects aged 1884, with known values for race and gender at risk for NHL and RCC. Among these, 181 009 were diagnosed with NHL, 118 122 were diagnosed with RCC and 1039 had both NHL and RCC. This was significantly higher than the expected number of 24 with co-existent NHL and RCC (p < 0.0001). The observed number (O) of RCC after NHL was significantly higher than the expected number (E) (O/E: 1.51; 95% confidence interval [CI] 1.361.66), with the O/E ratio remaining elevated across the various follow-up time intervals. The observed number of NHL after RCC was not significantly different from the expected number (O/E: 1.09; 95% CI 0.981.22). In univariate analyses, race and gender were significantly associated with an increased cumulative incidence of RCC after NHL. Multivariate analysis with age, race and gender revealed that white males had a higher cumulative incidence of RCC after NHL. These findings suggest that patients with NHL are at increased risk for RCC.

AB - The incidence of patients with multiple primary tumors has been increasing in recent years. The association between non-Hodgkin lymphomas (NHL) and renal cell carcinoma (RCC) is unclear. The presentation of 10 patients with co-existent NHL and RCC at our institution in the past 3 years led us to explore whether this was a chance association or a statistically significant phenomenon. We used the US Surveillance, Epidemiology and End Results (SEER) program (www.seer.cancer.gov) from 1973 to 2006 to identify a total of 892 445 537 subjects aged 1884, with known values for race and gender at risk for NHL and RCC. Among these, 181 009 were diagnosed with NHL, 118 122 were diagnosed with RCC and 1039 had both NHL and RCC. This was significantly higher than the expected number of 24 with co-existent NHL and RCC (p < 0.0001). The observed number (O) of RCC after NHL was significantly higher than the expected number (E) (O/E: 1.51; 95% confidence interval [CI] 1.361.66), with the O/E ratio remaining elevated across the various follow-up time intervals. The observed number of NHL after RCC was not significantly different from the expected number (O/E: 1.09; 95% CI 0.981.22). In univariate analyses, race and gender were significantly associated with an increased cumulative incidence of RCC after NHL. Multivariate analysis with age, race and gender revealed that white males had a higher cumulative incidence of RCC after NHL. These findings suggest that patients with NHL are at increased risk for RCC.

KW - Non-Hodgkin lymphoma

KW - Renal cell carcinoma

KW - SEER

UR - http://www.scopus.com/inward/record.url?scp=82255192994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255192994&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.603443

DO - 10.3109/10428194.2011.603443

M3 - Article

C2 - 21740306

AN - SCOPUS:82255192994

VL - 52

SP - 2254

EP - 2261

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 12

ER -